Historique
Rapport
The global state of harm reduction 2022
Auteur(s) :
HRI (Harm Reduction International)
Année
2022
Page(s) :
152 p.
Langue(s) :
Anglais
Éditeur(s) :
London : HRI (Harm Reduction International)
, 8th edition
Refs biblio. :
dissém.
Domaine :
Autres substances / Other substances ; Drogues illicites / Illicit drugs
Thésaurus géographique
INTERNATIONAL
;
EUROPE
;
ASIE
;
CARAIBES
;
AMERIQUE
;
OCEANIE
;
AFRIQUE
Thésaurus mots-clés
VIH
;
HEPATITE
;
PRISON
;
REDUCTION DES RISQUES ET DES DOMMAGES
;
POLITIQUE
;
INJECTION
;
ECHANGE DE SERINGUES
;
SUBSTITUTION
;
SURDOSE
;
PRODUIT ILLICITE
;
EFFICACITE
;
ACCES AUX SOINS
;
EPIDEMIOLOGIE
;
GEOGRAPHIE
;
TRAITEMENT DE MAINTENANCE
;
FENTANYL
;
MORTALITE
;
SALLE DE CONSOMMATION A MOINDRE RISQUE
;
NALOXONE
;
MILIEU FESTIF
;
FINANCEMENT
Résumé :
The Global State of Harm Reduction is the only report that provides an independent analysis of harm reduction in the world. Now in its the eighth edition, the Global State of Harm Reduction 2022 is the most comprehensive global mapping of harm reduction responses to drug use, HIV and viral hepatitis.
The period from 2020 to 2022 has seen increased uptake of harm reduction interventions. For the first time since 2014, the Global State of Harm Reduction has found an increase in the number of countries implementing key harm reduction services.
This growth has been driven by new needle and syringe programmes (NSPs) opening in five African countries as well as four new countries having officially sanctioned drug consumption rooms (DCRs). This includes a site in Mexico that had been operating without formal approval since 2018 but now has approval from local authorities. Three countries have introduced opioid agonist therapy (OAT) for the first time.
No country has stopped the implementation of NSP, OAT or DCRs since 2020.
The period from 2020 to 2022 has seen increased uptake of harm reduction interventions. For the first time since 2014, the Global State of Harm Reduction has found an increase in the number of countries implementing key harm reduction services.
This growth has been driven by new needle and syringe programmes (NSPs) opening in five African countries as well as four new countries having officially sanctioned drug consumption rooms (DCRs). This includes a site in Mexico that had been operating without formal approval since 2018 but now has approval from local authorities. Three countries have introduced opioid agonist therapy (OAT) for the first time.
No country has stopped the implementation of NSP, OAT or DCRs since 2020.
Affiliation :
UK
Titre précédent :